Insider Cluster Buy: ADARx Pharmaceuticals (ADRX) Insiders Bought $44M of Stock
5 insiders reported purchases of ADRX totaling $44.4M in what appears to be a public offering.
5 insiders at ADARx Pharmaceuticals, Inc. (ADRX) reported buying a combined $44.4M of company stock across 3 purchases in the past two weeks, at an average price of $17.00. The stock now trades at $17.68, +4.0% from their average cost.
Some purchases were reported by more than one filer (for example, a venture fund and the partner who sits on the board). We count each of those purchases once.
Every purchase was made on the same day at the same price, which usually means insiders bought shares in a public offering rather than on the open market. Offering purchases still show insiders putting new money in, but they're a different signal from open-market buying.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Sr One Capital Management, Llc / Simeon George | 10% Owner | Sep 28 | 1.60M | $27.2M |
| Carl L Gordon / Orbimed Advisors Llc | Director, 10% Owner | Sep 28 | 950,000 | $16.1M |
| Erez Chimovits | Director | Sep 28 | 61,516 | $1.0M |
Written by the GTA Research Desk from GTA Terminal data. Not investment advice.
Get stories like this in your inbox
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.